Literature DB >> 9084036

Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans.

S Kohlstädt1, P Couissinier-Paris, A Bourgois, B Bouchon, K Piper, H Kolbe, A J Dessein.   

Abstract

Parasite antigens that are strong T cell immunogens represent potential candidates for vaccines against pathogens susceptible to T cell-mediated immunity. We have previously shown that chromatographic fractions of schistosomula extracts contain components that are major T cell immunogen(s) in natural schistosome infections in humans and might contribute to the induction of human protective immunity against this parasite. In the present study, we report on the molecular cloning and on the biochemical characterization of the active components of these fractions. The screening of a schistosomula cDNA expression library with antibodies raised against the fractions allowed the cloning of a cDNA that hybridized to a 0.56-kb mRNA of schistosomula and adult worms. This cDNA contains an open reading frame of 267 base pairs (bp) which encodes a 10-kDa polypeptide. The analysis of the cDNA sequence revealed 70% homology with the sequences of previously reported proteins of unknown function. The native molecules in the active fractions were analyzed by mass spectrometry after additional purification by reverse phase high-performance liquid chromatography (HPLC). This procedure revealed two components in the fractions of molecular mass 10383 +/- 2 Da and 10401 +/- 9 Da. Both polypeptides stimulated immune T cells and yielded tryptic peptides whose sequences matched the sequence of the cloned molecule. These two polypeptides probably correspond to different post-translationally modified forms of the polypeptide encoded by the cloned cDNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084036     DOI: 10.1016/s0166-6851(96)02787-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  6 in total

1.  Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population.

Authors:  G J Waine; W Yang; A G Ross; Y S Li; A C Sleigh; B H Kalinna; J C Scott; D Mazzer; Y Li; D P McManus
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Isolation of T-cell antigens by using a recombinant protein library and its application to the identification of novel vaccine candidates against schistosomiasis.

Authors:  M Eberl; A P Mountford; D Jankovic; E Beck
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

4.  Antischistosomal Activity of Two Active Constituents Isolated from the Leaves of Egyptian Medicinal Plants.

Authors:  Sanaa A Ali; Nagy S El-Regal; Samar M Saeed
Journal:  Infect Dis (Auckl)       Date:  2015-06-15

5.  Developmental gene expression profiles of the human pathogen Schistosoma japonicum.

Authors:  Geoffrey N Gobert; Luke Moertel; Paul J Brindley; Donald P McManus
Journal:  BMC Genomics       Date:  2009-03-25       Impact factor: 3.969

Review 6.  A Review of Nanotechnology for Targeted Anti-schistosomal Therapy.

Authors:  Tayo Alex Adekiya; Pierre P D Kondiah; Yahya E Choonara; Pradeep Kumar; Viness Pillay
Journal:  Front Bioeng Biotechnol       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.